COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort studyJérôme Avouac, Pierre Barbery, Hubert Marotte et al.|The Lancet Rheumatology|2021Cited by 292
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 studyG. Martin de Frémont, Antoine Baudet, N. Costedoat‐Chalumeau et al.|The Lancet Rheumatology|2023Cited by 37
Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational studyAnne Murarasu, C. Bélizna, G. Guettrot-Imbert et al.|The Lancet Rheumatology|2022Cited by 24
Comment on: Hydroxychloroquine levels in pregnancy and materno–fetal outcomes in Systemic Lupus Erythematosus patients: ReplyGelsomina Alle, C. Durant, G. Guettrot-Imbert et al.|Lara D. Veeken|2024Cited by 1